iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Reaches New 52-Week High – What’s Next?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)’s share price reached a new 52-week high during trading on Wednesday. The company traded as high as $110.79 and last traded at $110.73, with a volume of 208,462 shares traded. The stock had previously closed at $110.46.

iShares U.S. Pharmaceuticals ETF Trading Up 0.4%

The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47. The firm has a 50 day moving average price of $102.73 and a two-hundred day moving average price of $95.49.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of IHE. Fisher Asset Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the third quarter valued at approximately $271,848,000. Bank of America Corp DE raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 2.8% in the 1st quarter. Bank of America Corp DE now owns 456,606 shares of the company’s stock valued at $39,579,000 after acquiring an additional 12,565 shares during the period. MinichMacGregor Wealth Management LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $32,098,000. McElhenny Sheffield Capital Management LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $13,201,000. Finally, Insight Wealth Strategies LLC lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.3% during the 2nd quarter. Insight Wealth Strategies LLC now owns 122,642 shares of the company’s stock valued at $12,055,000 after acquiring an additional 3,950 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.